Astria Therapeutics, Inc. (ATXS)
NASDAQ: ATXS · Real-Time Price · USD
5.36
-0.35 (-6.05%)
Mar 31, 2025, 1:29 PM EDT - Market open
Astria Therapeutics Employees
Astria Therapeutics had 78 employees as of December 31, 2024. The number of employees increased by 19 or 32.20% compared to the previous year.
Employees
78
Change (1Y)
19
Growth (1Y)
32.20%
Revenue / Employee
n/a
Profits / Employee
-$1,208,462
Market Cap
302.21M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
ATXS News
- 20 days ago - Astria Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides a Corporate Update - Business Wire
- 26 days ago - Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 4 weeks ago - Astria Therapeutics Initiates ALPHA-ORBIT Phase 3 Pivotal Trial of Navenibart in Hereditary Angioedema - Business Wire
- 4 weeks ago - Astria Therapeutics to Present at Upcoming TD Cowen 45th Annual Health Care Conference - Business Wire
- 5 weeks ago - Astria Therapeutics to Present at Upcoming American Academy of Allergy, Asthma and Immunology and World Allergy Organization Joint Congress - Business Wire
- 5 weeks ago - Astria Therapeutics: A High-Conviction Bet On HAE - Seeking Alpha
- 7 weeks ago - Astria Therapeutics to Present at Upcoming Oppenheimer 35th Annual Healthcare Life Sciences Conference - Business Wire
- 2 months ago - Astria Therapeutics to Present at Upcoming Western Society of Allergy, Asthma & Immunology Annual Scientific Session - Business Wire